The Council of the European Union has published a second set of corrections as part of a corrigendum for the EU’s Medical Devices Regulation (MDR), this time giving manufacturers of certain Class I devices an additional four years to comply.
News & Trends
Procurar
Recentes
- HTA Regulation – Commission selects first medical devices for joint clinical assessment
- PHARMACOVIGILANCE UPDATE | FDA E2B(R3) IMPLEMENTATION GUIDE — OCTOBER 2026
- updated PIC/S PI 006-4 guideline RECOMMENDATIONS ON QUALIFICATION AND VALIDATION
- Annual report of the Pharmacovigilance Inspectors Working Group for 2025
- European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
- ACT EU workplan 2026 – 2027
- Advice on ‘end-of-year’ submission dates for type I variations in 2026
- EMA UPDATE : COMPLIANCE with EU GMP Annex 22 and Artificial Intelligence Standards

